首页> 美国卫生研究院文献>Bulletin of the World Health Organization >Recent developments in vaccination against malaria: Nor-MDP saponin corynebacteria and pertussis organisms as immunological adjuvants in experimental malaria vaccination of macaques
【2h】

Recent developments in vaccination against malaria: Nor-MDP saponin corynebacteria and pertussis organisms as immunological adjuvants in experimental malaria vaccination of macaques

机译:疟疾疫苗接种的最新进展:诺-MDP皂苷棒状杆菌和百日咳菌作为猕猴实验性疟疾疫苗免疫佐剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vaccination of primates against malaria using antigen derived from erythrocytic parasite stages has been most successful where Freund's complete adjuvant has been employed. Since this adjuvant is clinically unacceptable its replacement is a matter of urgency.In the present work a muramyldipeptide derivative (nor-MDP) given in mineral oil has proved to be partially effective as an adjuvant for merozoite vaccination of Macaca mulatta against Plasmodium knowlesi, and saponin has proved to be effective in similar vaccination of M. fascicularis.
机译:在使用弗氏完全佐剂的情况下,使用源自红细胞寄生虫阶段的抗原对灵长类动物进行疟疾疫苗接种最为成功。由于该佐剂在临床上是不可接受的,因此迫切需要更换。在目前的工作中,已证明在矿物油中给予的muramyldipeptide衍生物(nor-MDP)可以作为部分食肉猴的裂殖子疫苗来预防猕猴的疟原虫,以及皂苷已被证明可有效地对fas。fascicularis进行类似的疫苗接种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号